Observed and expected deaths,2-150standardised mortality ratios (SMRs) (95% CIs), with state rates for white men as the reference
| Cause of death (ICD-9 code) | Obs | Exp | SMR | 95% CI |
| All causes (001–999) | 3191 | 3831.31 | 83 | 80 to 86 |
| All malignant neoplasms (140–205) | 895 | 935.35 | 96 | 90 to 102 |
| Buccal cavity and pharynx (140–148) | 24 | 22.91 | 105 | 67 to 156 |
| Tongue (141) | 10 | 4.96 | 202 | 97 to 371 |
| Other parts of buccal cavity (142–145) | 5 | 5.73 | 87 | 28 to 204 |
| Pharynx (146–148) | 8 | 11.76 | 68 | 29 to 134 |
| Digestive system (150–159) | 253 | 214.79 | 118 | 104 to 133 |
| Oesophagus (150) | 26 | 22.00 | 118 | 77 to 173 |
| Stomach (151) | 22 | 29.06 | 76 | 47 to 115 |
| Intestine, except rectum (152–153) | 64 | 76.89 | 83 | 64 to 106 |
| Rectum (154) | 16 | 17.60 | 91 | 52 to 148 |
| Liver and biliary tract (155–156) | 80 | 22.30 | 359 | 284 to 446 |
| Pancreas (157) | 37 | 43.24 | 86 | 60 to 118 |
| Peritoneum/other/unspecified digestive (158–159) | 8 | 3.70 | 216 | 93 to 427 |
| Respiratory system (160–165) | 315 | 385.81 | 82 | 73 to 91 |
| Larynx (161) | 6 | 13.03 | 46 | 17 to 100 |
| Trachea, bronchus, and lung (162) | 303 | 369.45 | 82 | 73 to 92 |
| Other parts respiratory (160, 163–165) | 6 | 3.33 | 180 | 66 to 392 |
| Breast (175) | 2 | 1.05 | 190 | 23 to 687 |
| Male genital organs (185–187) | 54 | 63.98 | 84 | 63 to 110 |
| Prostate (185) | 52 | 60.34 | 86 | 64 to 113 |
| Other male genital organs (186–187) | 2 | 3.64 | 55 | 7 to 198 |
| Urinary organs (188–189) | 47 | 44.07 | 107 | 78 to 142 |
| Kidney (189.0–189.2) | 25 | 23.11 | 108 | 70 to 160 |
| Bladder (188, 189.3–189.9) | 22 | 20.96 | 105 | 66 to 159 |
| Skin (172–173) | 12 | 18.77 | 64 | 33 to 112 |
| Eye (199) | 2 | 0.70 | 286 | 35 to 1033 |
| Brain and CNS (191–192) | 36 | 25.29 | 142 | 100 to 197 |
| Thyroid gland (193) | 2 | 1.53 | 131 | 16 to 472 |
| Bone (170) | 4 | 3.33 | 120 | 33 to 307 |
| Connective tissue and soft tissue (171) | 12 | 4.44 | 270 | 139 to 472 |
| Other/unspecified sites (194–199) | 61 | 65.84 | 93 | 71 to 119 |
| Neoplasms of lymphatic and haematopoietic tissue (200–208) | 71 | 82.83 | 86 | 67 to 108 |
| Lymphosarcoma or reticulosarcoma (200) | 12 | 10.02 | 120 | 62 to 209 |
| Hodgkin's disease (201) | 3 | 6.77 | 44 | 9 to 129 |
| Leukaemia and aleukaemia (204–208) | 31 | 32.82 | 94 | 64 to 134 |
| Other neoplasms of lymphatic and haematopoietic tissue (202–203) | 25 | 33.22 | 75 | 49 to 111 |
| Benign neoplasms (210–239) | 12 | 10.96 | 109 | 56 to 191 |
| Neoplasms of unspecified nature of eye, brain, and nervous system (237.5–237.9, 239.6–239.7) | 6 | 5.30 | 113 | 41 to 246 |
| Other benign and unspecified neoplasms (210–223, 226–237.4, 238.0–239.5, 239.8–239.9) | 6 | 4.49 | 134 | 49 to 291 |
↵2-150 Results are presented for all categories of neoplasms for which there were two observed or two expected deaths.